Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
26 Novembre 2024 - 10:30PM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage
biopharmaceutical company focused on developing novel drug
candidates for immuno-inflammatory diseases, today announced that
members of the Aclaris management team will participate in a
fireside chat during the Piper Sandler 36th Annual Healthcare
Conference on Tuesday, December 3, 2024 at 1:00 PM ET in New York,
New York.
A webcast of the fireside chat may be accessed through the
“Events” page of the “Investors” section of Aclaris’ website,
www.aclaristx.com. The webcast will be archived for at least 30
days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical
company developing a pipeline of novel drug candidates to address
the needs of patients with immuno-inflammatory diseases who lack
satisfactory treatment options. The company has a multi-stage
portfolio of drug candidates powered by a robust R&D engine
exploring protein kinase regulation. For additional information,
please visit www.aclaristx.com.
Aclaris Therapeutics Contact:
investors@aclaristx.com
Grafico Azioni Aclaris Therapeutics (NASDAQ:ACRS)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Aclaris Therapeutics (NASDAQ:ACRS)
Storico
Da Gen 2024 a Gen 2025
